At Tuesday’s closing price, Mankind Pharma was valued at a price-to-earnings ratio of 43 times its FY22 earnings. Mankind is now India’s fifth largest pharma company by market value of ₹57,046 crore. Sun Pharma, Divi’s Lab, Dr. Reddy’s Lab, and Cipla are currently valued between ₹75,284 crore and ₹2.31 lakh crore.
Warren Buffett’s 7 golden rules for young investors trying to manage finances
Warren Buffett shares seven essential financial lessons for young investors, emphasising frugal living, eliminating high-interest debt, long-term investing, understanding businesses, maintaining cash reserves and portfolio